Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and aggregation: a systematic review and meta-analysis

[1]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, International Coaching Psychology Review.

[2]  J. Wo,et al.  Study on the effect of different doses of rosuvastatin on ventricular remodeling in patients with acute coronary syndrome after emergency percutaneous coronary intervention. , 2017, European review for medical and pharmacological sciences.

[3]  S. de Servi,et al.  Effects of statin therapy on platelet reactivity after percutaneous coronary revascularization in patients with acute coronary syndrome , 2017, Journal of Thrombosis and Thrombolysis.

[4]  T. Hong,et al.  Platelet reactivity and clinical outcomes in patients using CYP3A4-metabolized statins with clopidogrel in percutaneous coronary intervention , 2017, Heart and Vessels.

[5]  A. Colombo,et al.  Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study , 2017, Clinical cardiology.

[6]  U. Laufs,et al.  Pleiotropic Effects of Statins on the Cardiovascular System , 2017, Circulation research.

[7]  J. B. Nagavi,et al.  Omeprazole and atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation in patients undergoing percutaneous coronary intervention in a tertiary health care system: A prospective drug–drug interaction study , 2016 .

[8]  R. Kovacs,et al.  Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention , 2016, Clinical pharmacology : advances and applications.

[9]  Ya-jie Liu,et al.  Efficacy of Clopidogrel and Clinical Outcome When Clopidogrel Is Coadministered With Atorvastatin and Lansoprazole , 2015, Medicine.

[10]  S. Villani,et al.  Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study. , 2014, American heart journal.

[11]  H. Reichmann,et al.  Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover study. , 2014, British journal of clinical pharmacology.

[12]  M. Cho,et al.  Relationship between statin type and responsiveness to clopidogrel in patients treated with percutaneous coronary intervention: a subgroup analysis of the CILON-T trial. , 2014, Journal of atherosclerosis and thrombosis.

[13]  G. Rosano,et al.  Pharmacodynamic effects of atorvastatin versus rosuvastatin in coronary artery disease patients with normal platelet reactivity while on dual antiplatelet therapy--the PEARL randomized cross-over study. , 2014, European journal of pharmacology.

[14]  E. Antman,et al.  Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). , 2013, JACC. Cardiovascular interventions.

[15]  B. Giusti,et al.  High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study. , 2013, JACC. Cardiovascular interventions.

[16]  H. Bøtker,et al.  Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation. , 2012, British journal of clinical pharmacology.

[17]  F. Fonseca,et al.  Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease. , 2012, International journal of cardiology.

[18]  D. Roden,et al.  Genetic determinants of response to cardiovascular drugs , 2012, Current opinion in cardiology.

[19]  H. Hod,et al.  Statins have an early antiplatelet effect in patients with acute myocardial infarction , 2011, Platelets.

[20]  P. Morange,et al.  Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation). , 2010, Thrombosis research.

[21]  B. Giusti,et al.  Response to antiplatelet treatment: from genes to outcome , 2010, The Lancet.

[22]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[23]  M. Zwahlen,et al.  A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents , 2010, Thrombosis and Haemostasis.

[24]  J. Tardif,et al.  Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study. , 2010, Archives of cardiovascular diseases.

[25]  P. Neuvonen.  Drug interactions with HMG-CoA reductase inhibitors (statins): the importance of CYP enzymes, transporters and pharmacogenetics. , 2010, Current opinion in investigational drugs.

[26]  P. Hjemdahl,et al.  Influence of statin treatment on platelet inhibition by clopidogrel – a randomized comparison of rosuvastatin, atorvastatin and simvastatin co‐treatment , 2009, Journal of internal medicine.

[27]  F. Barillà,et al.  Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients , 2009, Journal of Thrombosis and Thrombolysis.

[28]  J. Brophy,et al.  Investigation of an interaction between statins and clopidogrel after percutaneous coronary intervention: a cohort study , 2009, Pharmacoepidemiology and Drug Safety.

[29]  Z. Motovska,et al.  Factors Influencing Clopidogrel Efficacy in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention: Statin's Advantage and the Smoking “Paradox” , 2009, Journal of cardiovascular pharmacology.

[30]  M. Gawaz,et al.  Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy. , 2008, European heart journal.

[31]  C. Cannon,et al.  High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis. , 2008, American heart journal.

[32]  F. Neumann,et al.  Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement , 2007, Thrombosis and Haemostasis.

[33]  D. Angiolillo,et al.  Clopidogrel-statin interaction: myth or reality? , 2007, Journal of the American College of Cardiology.

[34]  D. Angiolillo,et al.  Randomized Comparison of a High Clopidogrel Maintenance Dose in Patients With Diabetes Mellitus and Coronary Artery Disease: Results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) Study , 2007, Circulation.

[35]  O. Hess,et al.  Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis. , 2007, The American journal of cardiology.

[36]  Deepak L. Bhatt,et al.  Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. , 2006, Journal of the American College of Cardiology.

[37]  J. Brophy,et al.  A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention. , 2006, American heart journal.

[38]  Y. Daali,et al.  Not all statins interfere with clopidogrel during antiplatelet therapy , 2005, European journal of clinical investigation.

[39]  J. Goudevenos,et al.  The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes. , 2005, Platelets.

[40]  K. Eagle,et al.  Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. , 2005, European heart journal.

[41]  K. Eagle,et al.  Lack of clopidogrel–CYP3A4 statin interaction in patients with acute coronary syndrome , 2004, Heart.

[42]  R. Storey,et al.  Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention , 2004, Platelets.

[43]  A. Kastrati,et al.  Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting. , 2004, European heart journal.

[44]  C. O'connor,et al.  Absence of Interaction Between Atorvastatin or Other Statins and Clopidogrel: Results From the Interaction Study , 2004 .

[45]  P. Martus,et al.  ADP induced platelet degranulation in healthy individuals is reduced by clopidogrel after pretreatment with atorvastatin , 2004, Thrombosis and Haemostasis.

[46]  J. Goudevenos,et al.  Atorvastatin Does Not Affect the Antiplatelet Potency of Clopidogrel When It Is Administered Concomitantly for 5 Weeks in Patients With Acute Coronary Syndromes , 2004, Circulation.

[47]  Zhongyan Li,et al.  Effects of Statins on Platelet Inhibition by a High Loading Dose of Clopidogrel , 2003, Circulation.

[48]  MeinradGawaz,et al.  Effects of Statins on Platelet Inhibition by a High Loading Dose of Clopidogrel , 2003 .

[49]  M. Spiecker,et al.  Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function--a flow cytometry study. , 2003, European heart journal.

[50]  S. Steinhubl,et al.  Lack of Adverse Clopidogrel–Atorvastatin Clinical Interaction From Secondary Analysis of a Randomized, Placebo-Controlled Clopidogrel Trial , 2003, Circulation.

[51]  T. Heer,et al.  Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. , 2003, The American journal of cardiology.

[52]  Paul B. Watkins,et al.  Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation: A New Drug–Drug Interaction , 2003, Circulation.

[53]  A. Kastrati,et al.  Statin treatment following coronary artery stenting and one-year survival. , 2002, Journal of the American College of Cardiology.

[54]  S. Steinhubl,et al.  Statins do not affect platelet inhibition with clopidogrel during coronary stenting. , 2001, Atherosclerosis.

[55]  Judy W. M. Cheng,et al.  Beneficial Effects of Statins in Coronary Artery Disease — Beyond Lowering Cholesterol , 2000, The Annals of pharmacotherapy.

[56]  J. Herbert,et al.  Identification and Biological Activity of the Active Metabolite of Clopidogrel , 2000, Thrombosis and Haemostasis.

[57]  P. Morange,et al.  074 Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome , 2012 .

[58]  C. O'connor,et al.  Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study. , 2004, Archives of internal medicine.

[59]  L. Waskell,et al.  The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin. , 2003, Drug metabolism and disposition: the biological fate of chemicals.